Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine?

Nature Clinical Practice Neurology volume 2, pages 24–25 (2006)Cite this article

boxed-textSchrader J et al. (2005) Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36: 1218–1226

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041. Errata in Lancet (2001) 358: 1556 and Lancet (2002) 359: 2120

  2. Turnbull F ; Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362: 1527–1535

    Article  CAS  Google Scholar 

  3. Dahlof B et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995–1003

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Emma Campbell, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of the Stroke Service and Associate Professor of Neurology and Epidemiology at the University of California, San Francisco, CA, USA

    S Claiborne Johnston

Authors
  1. S Claiborne Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Claiborne Johnston.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnston, S. Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine?. Nat Rev Neurol 2, 24–25 (2006). https://doi.org/10.1038/ncpneuro0090

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0090

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing